NCT04129216View on ClinicalTrials.gov

The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 20, 2019

Primary Completion Date

November 10, 2022

Study Completion Date

November 10, 2022

Conditions
Breast Cancer
Interventions
DRUG

Tamoxifen Citrate

10mg administered daily. Patients take this drug for 2-6 weeks

DRUG

Letrozole

2.5mg is administered daily. Patients take this drug for 2-6 weeks

DRUG

Exemestane

25mg is administered daily. Patients take this drug for 2-6 weeks.

DIAGNOSTIC_TEST

Blueprint

studies the genomics of the tumor and tumor behavior

DIAGNOSTIC_TEST

Mammaprint

studies the genomics of the tumor

Trial Locations (1)

21224

Johns Hopkins Bayview Hospital, Baltimore

Sponsors

Collaborators (1)

Agendia
All Listed Sponsors
collaborator

Agendia

INDUSTRY

lead

Johns Hopkins University

OTHER

NCT04129216 - The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer | Biotech Hunter | Biotech Hunter